Authors
Loading...
Randomized trial characterizes monoclonal antibodies targeting doisurface proteins of rhesus rotavirus, indicating potential for therapeutic use.
Greenberg et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: